Verantos Public Market Comparables
Find the most relevant public market comparables for Verantos, including EV/Revenue and EV/EBITDA multiples to help you make informed investment decisions.
Company Overview
Verantos is a real-world evidence (RWE) company specializing in generating high-validity evidence for clinical, regulatory, and reimbursement purposes. It uses AI and clinical narrative data from various sources (electronic health records, medical claims, product and disease registries) to produce reliable RWE for life sciences firms, payers, providers, and regulators.
Business Model
Software as a Service (SaaS) platform providing real-world evidence (RWE) generation and data analysis services to life sciences companies and other healthcare stakeholders.
Target Customers
Top-tier biotechnology and pharmaceutical firms, leading academic medical centers, health systems, the Food and Drug Administration (FDA), the National Institutes of Health (NIH), and the National Science Foundation (NSF).
Specific Focus
High-validity real-world evidence generation at scale using AI and advanced data integration techniques.
Location
Menlo Park, California
CEO
Dan Riskin
Industry
Life sciences
Sub Sector
Bioinformatics, Real-World Evidence
3yr Revenue Growth
368%
Website
Public Market Comparables
Below are the key valuation metrics for companies similar to Verantos in the Life Sciences sector. These metrics can help you understand how the market values companies with similar business models and growth profiles.
Looking for a comprehensive compset for Verantos? Our platform provides detailed analysis of Verantos's competitive landscape, including financial metrics, growth trends, and market positioning. Get access to the full Verantos compset by trying our platform today.
EV/Revenue Multiple
Min
0.0x
Median
0.0x
Max
00.0x
Unlock actual values by trying our platform
View Full DetailsEV/EBITDA Multiple
Min
00.0x
Median
00.0x
Max
00.0x
Unlock actual values by trying our platform
View Full Details
Unlock the Full Verantos Compset
As a leading player in the Life sciences industry within the Life Sciences sector, Verantos operates in the specialized Bioinformatics, Real-World Evidence sub-sector. Understanding how Verantos compares to its public market comps is essential for accurate valuation and strategic decision-making.
Our comprehensive analysis includes detailed comparables (compsets) featuring similar companies in the Bioinformatics, Real-World Evidence space, with complete financial metrics, growth trajectories, and competitive positioning insights that go beyond the surface-level data shown above.
Other Interesting Companies
BenchSci
Life Sciences • Life sciences
BenchSci develops ASCEND, an AI-powered platform that helps scientists accelerate drug discovery and improve patient outcomes by providing an unmatched understanding of disease biology. It uses machine learning and artificial intelligence to translate both closed and open-access data into recommendations for specific experiments, enabling researchers to run successful experiments faster and more efficiently.
1upHealth, Inc.
Healthcare Technology • Software & services
1upHealth provides a modern, cloud-based, API-enabled, and FHIR-native health data platform designed for claims and clinical data acquisition, exchange, and compute. It serves health plans, state Medicaid agencies, digital health organizations, and Accountable Care Organizations (ACOs) to securely access, manage, and analyze large volumes of healthcare data. The platform supports interoperability and regulatory compliance, assisting organizations in meeting requirements for digital quality measures, population health analytics, and value-based contracts.
Seer, Inc.
Healthcare • Life sciences
Seer, Inc. is a life sciences company that develops and commercializes products to decode the biology of the proteome. Their Proteograph Product Suite is an integrated solution including engineered nanoparticles, consumables, automation instrumentation, and data analysis software for proteomic analysis. Products are for research use only and target academic institutions, life sciences and research laboratories, as well as biopharmaceutical and biotechnology companies.
Get Your Custom Comparable Analysis
Need a more detailed analysis of Verantos and its public market comparables? Our platform provides comprehensive valuation metrics, growth analysis, and more.
Try CompsetFinder Free